AKT1 and head and neck squamous cell carcinoma: Other molecular determinants of HNSCC are mutations and polymorphisms in epidermal growth factor receptor, PI3 K (phosphatidylinositol 3-kinase), AKT (protein kinase B, PKB), and p16 (cyclin-dependent kinase inhibitor 2A) pathways.